Abstract PD8-05: A Retrospective Cohort Study on Mitigating Chemotherapy Side Effects in Breast Cancer Patients: The Role of GLP-1 Agonists
E. Obomanu(Jefferson Hospital), C. Dourado(Jefferson Hospital), Muluken Megiso(Jefferson Hospital), Avinash Ramkissoon(Joe DiMaggio Children's Hospital), Sam King(Jefferson Hospital), C. Jones(The University of Texas at San Antonio), Akshay Ratnani(Jefferson Hospital), C. Ugwu(Jefferson Hospital), Tarfa Verinumbe(Albert Einstein College of Medicine)
Cited by 1
Related Papers
Scale-up of antiretroviral treatment access among people living with HIV in Rivers State, Nigeria, 2019--2020
|AIDS|2021|16
Characterizing the Relationship between HIV Peer Support Groups and Internalized Stigma Among People Living with HIV in Nigeria
|AIDS and Behavior|2023|15
Associations of HIV pre-exposure prophylaxis (PrEP) indication, HIV risk perception and unwillingness to use PrEP among people who inject drugs in Baltimore, MD
|Drug and Alcohol Dependence Reports|2024|4
GLP-1 receptor agonist vs aspirin for primary prevention of colorectal cancer: Evidence from a real-world head-to-head comparison.
|Journal of Clinical Oncology|2026|3